Mitchell Gold, Executive Chairman and CEO at ALPINE IMMUNE SCIENCES, INC. (ALPN), sold 203,550 shares at $17.08 ($3.5M) on 2023-12-08, disclosed to the SEC on 2023-12-12.
Scheduled sale ($3.5M) by Executive Chairman and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.08 | 8,067 | $138K | 3.9% |
| 2 | $17.08 | 8,067 | $138K | 3.9% |
| 3 | $17.26 | 68,870 | $1.2M | 33.8% |
| 4 | $17.26 | 68,870 | $1.2M | 33.8% |
| 5 | $17.32 | 8,613 | $149K | 4.2% |
| 6 | $17.32 | 8,613 |
| $149K |
| 4.2% |
| 7 | $17.32 | 32,450 | $562K | 16.0% |
| Total | $17.26 avg | 203,550 | $3.5M | 100% |
| Filing → |
| ALPN | SELL | 2023-12-21 | $48K | — | Filing → |
| ALPN | SELL | 2021-09-21 | $4.7M | — | Filing → |
| ALPN | SELL | 2021-09-17 | $103K | — | Filing → |